PubMed · 2020

Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial

Garvey WT, Birkenfeld AL, Dicker D, Mingrone G (2020). Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial. Diabetes care.

Diabetes care

Source: https://pubmed.ncbi.nlm.nih.gov/32139381/

Last reviewed September 19, 2026. By the PeptIQ team.

View original source

Peptides linked in PeptIQ Wiki

Liraglutide — community report

This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.